Answer
Nov 25, 2024 - 02:52 PM
Vyzulta (Latanoprostene bunod) and Latanoprost are both medications used to lower intraocular pressure in patients with glaucoma or ocular hypertension. The key difference is that Vyzulta has a dual mechanism of action: it not only increases the outflow of aqueous humor through the uveoscleral pathway like latanoprost, but it also releases nitric oxide, which further enhances outflow through the trabecular meshwork. This dual action potentially offers greater efficacy in reducing intraocular pressure.
